Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

INNO-206 shrinks human tumors in an animal model of multiple myeloma

May 6, 2010

AdventRx presents 6-month stability data for ANX-530

May 6, 2010

Celator reports data from phase II Cpx-351 study in acute myeloid leukemia

May 5, 2010

Curis completes enrollment and treatment in phase I study of CUDC-101 in cancer

May 5, 2010

NOXXON completes first phase I study of Spiegelmer NOX-A12

May 5, 2010

Pan-CDK inhibitor BAY-1000394 exhibits favorable pharmacologic profile in preclinical evaluation

May 5, 2010

Preclinical data on nucleolin-binding peptide EP-302 support further development in cancer therapy

May 5, 2010

Novel CRAC inhibitor synthesized at Incozen Therapeutics

May 5, 2010

Banyu and Merck & Co. disclose novel NFkappaB-inducing kinase inhibitors

May 5, 2010

BioCancell receives FDA approval to continue phase IIb bladder cancer trial

May 4, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...